Literature DB >> 15579067

Targeting the assembly of the human immunodeficiency virus type I.

D Muriaux1, J L Darlix, A Cimarelli.   

Abstract

In the rush to develop anti-viral drugs against the human immunodeficiency virus type I (HIV-1), all the steps of the viral life cycle are potential targets of therapeutic intervention. In this review, we will explore the recent advances on strategies that aim at obstructing the formation, the release and the infectivity of newly formed virion particles from HIV-1 infected cells.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15579067     DOI： 10.2174/1381612043382701

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN： 1381-6128            Impact factor:   3.116


  16 in total

Review 1.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.

Authors:  Audrey Thomas; Charlotte Mariani-Floderer; Maria Rosa López-Huertas; Nathalie Gros; Elise Hamard-Péron; Cyril Favard; Theophile Ohlmann; José Alcamí; Delphine Muriaux
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.

Authors:  E Hamard-Peron; F Juillard; J S Saad; C Roy; P Roingeard; M F Summers; J-L Darlix; C Picart; D Muriaux
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.

Authors:  Fabien Perugi; Delphine Muriaux; Bertha Cecilia Ramirez; Sabah Chabani; Etienne Decroly; Jean-Luc Darlix; Vincent Blot; Claudine Pique
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

5.  Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.

Authors:  Sawitree Nangola; Agathe Urvoas; Marie Valerio-Lepiniec; Wannisa Khamaikawin; Supachai Sakkhachornphop; Saw-See Hong; Pierre Boulanger; Philippe Minard; Chatchai Tayapiwatana
Journal:  Retrovirology       Date:  2012-02-20       Impact factor: 4.602

6.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

7.  Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay.

Authors:  Gaëlle Gonzalez; Sandrina DaFonseca; Elisabeth Errazuriz; Pascale Coric; Florence Souquet; Serge Turcaud; Pierre Boulanger; Serge Bouaziz; Saw See Hong
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

8.  Sensing peptide-oligonucleotide interactions by a two-color fluorescence label: application to the HIV-1 nucleocapsid protein.

Authors:  Volodymyr V Shvadchak; Andrey S Klymchenko; Hugues de Rocquigny; Yves Mély
Journal:  Nucleic Acids Res       Date:  2009-01-16       Impact factor: 16.971

9.  Intracellular assembly and budding of the Murine Leukemia Virus in infected cells.

Authors:  Laurent Houzet; Bernard Gay; Zakia Morichaud; Laurence Briant; Marylène Mougel
Journal:  Retrovirology       Date:  2006-02-10       Impact factor: 4.602

10.  6th international symposium on retroviral nucleocapsid.

Authors:  Ben Berkhout; Robert Gorelick; Michael F Summers; Yves Mély; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2008-02-25       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.